APA Zitierstil

Kudo, M. (2019). Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies. Liver Cancer.

Chicago Zitierstil

Kudo, Masatoshi. "Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma With Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies." Liver Cancer 2019.

MLA Zitierstil

Kudo, Masatoshi. "Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma With Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies." Liver Cancer 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.